You are here

SARC012

Active
A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung
Type of Sarcoma: 
Osteosarcoma
Drug: 
saracatinib and placebo
Accrual Status: 
Ongoing,Not Accruing
Overall Study Principal Investigator: 

Melinda Merchant, MD, PhD
Staff Clinician, Pediatric Oncology Branch
National Cancer Institute

For more information about this trial and open sites: